Post-cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspa- se-3-mediated Apoptosis Induction -Anti-lung cancer potential of Condurango 30C in rats-
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The present investigation aimed at examining if post-cancer treatment with a potentized homeopathic drug, Condurango 30C, which is generally used to treat oesophageal cancer, could also show an ameliorating effect through apoptosis induction on lung cancer induced by benzo[a]pyrene (BaP) in white rats (Rattus norvegicus). Methods: Lung cancer was induced after four months by chronic feeding of BaP to rats through gavage at a dose of 50 mg/kg body weight for one month. After four months, the lung-cancer-bearing rats were treated with Condurango 30C for the next one (5th), two (5th -6th) and three (5th-7th) months, respectively, and were sacrificed at the corresponding time- points. The ameliorating effect, if any, after Condurango 30C treatment for the various periods was evaluated by using protocols such as histology, scanning electron microscopy (SEM), annexinV-FITC/PI assay, flow cytometry of the apoptosis marker, DNA fragmentation, reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry, and western blot analyses of lung tissue samples. Results: Striking recovery of lung tissue to a near normal status was noticed after post-cancerous drug treatment, as evidenced by SEM and histology, especially after one and two months of drug treatment. Data from the annexinV-FITC/PI and DNA fragmentation assays revealed that Condurango 30C could induce apoptosis in cancer cells after post-cancer treatment. A critical analysis of signalling cascade, evidenced through a RT-PCR study, demonstrated up-regulation and down-regulation of different pro- and anti-apoptotic genes, respectively, related to a caspase-3-mediated apoptotic pathway, which was especially discernible after one-month and two- month drug treatments. Correspondingly, Western blot and immunohistochemistry studies confirmed the ameliorative potential of Condurango 30C by its ability to down-regulate the elevated epidermal growth factor receptor (EGFR) expression,a hallmark of lung cancer. Conclusion: The overall result validated a positive effect of Condurango 30C in ameliorating lung cancer through caspase-3-mediated apoptosis induction and EGFR down-regulation.
Abstract
Objectives: The present investigation aimed at examining if post-cancer treatment with a potentized homeopathic drug, Condurango 30C, which is generally used to treat oesophageal cancer, could also show an ameliorating effect through apoptosis induction on lung cancer induced by benzo[a]pyrene (BaP) in white rats (Rattus norvegicus). Methods: Lung cancer was induced after four months by chronic feeding of BaP to rats through gavage at a dose of 50 mg/kg body weight for one month. After four months, the lung-cancer-bearing rats were treated with Condurango 30C for the next one (5th), two (5th -6th) and three (5th-7th) months, respectively, and were sacrificed at the corresponding time- points. The ameliorating effect, if any, after Condurango 30C treatment for the various periods was evaluated by using protocols such as histology, scanning electron microscopy (SEM), annexinV-FITC/PI assay, flow cytometry of the apoptosis marker, DNA fragmentation, reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry, and western blot analyses of lung tissue samples. Results: Striking recovery of lung tissue to a near normal status was noticed after post-cancerous drug treatment, as evidenced by SEM and histology, especially after one and two months of drug treatment. Data from the annexinV-FITC/PI and DNA fragmentation assays revealed that Condurango 30C could induce apoptosis in cancer cells after post-cancer treatment. A critical analysis of signalling cascade, evidenced through a RT-PCR study, demonstrated up-regulation and down-regulation of different pro- and anti-apoptotic genes, respectively, related to a caspase-3-mediated apoptotic pathway, which was especially discernible after one-month and two- month drug treatments. Correspondingly, Western blot and immunohistochemistry studies confirmed the ameliorative potential of Condurango 30C by its ability to down-regulate the elevated epidermal growth factor receptor (EGFR) expression,a hallmark of lung cancer. Conclusion: The overall result validated a positive effect of Condurango 30C in ameliorating lung cancer through caspase-3-mediated apoptosis induction and EGFR down-regulation.
참고문헌 (23)
- Jemal A, "Cancer statistics", CA Cancer J Clin, 55, pp.10~30 (2005)
- pyrene 7, 8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions, "Chem Res Toxicol", 2000, 1046~1050
- pyrene-DNA adduct formation in human mammary epithelial cells, "Carcinogenesis", 2000, 2123~2127
- pyrene-induced lung cancer in mice, "Zhong Xi Yi Jie He Xue Bao", 2011, 320~327
- Vijayakumar MV, "The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway", Br J Pharmacol, 146(1), pp.41~48 (2005)
- Biswas SJ, "Evaluation of protective potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice", Indian J Exp Biol, 42(7), pp.698~714 (2004)
- Pathak S, "Protective potentials of a potentized homeopathic drug Lycopdium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice", Mol Cell Biochem, 285(1-2), pp.121~131 (2006)
- Asmita Samadder, "The Potentized Homeopathic Drug, Lycopodium clavatum (5C and 15C) Has Anti-cancer Effect on HeLa Cells In Vitro.", Journal of Acupuncture & Meridian Studies, 6(4), pp.180~187 (2013), 세계약침학회[DOI]
- Fulda S, "Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy", Oncogene, 25(34), pp.4798~4811 (2006)
- Katiyar SK, "p53 cooperates berberine-induced growth inhibition and apoptosis of non small cell human lung cancer cells in vitro and tumour xenograft growth in vivo", Mol Carcinog, 48(1), pp.24~37 (2009)
- Banerji P, "Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a best case series program of the National Cancer Institute USA", Oncol Rep, 20(1), pp.69~74 (2008)
- Wang R, "Traditional medicines used in differentiation therapy of myeloid leukemia", Asian Journal of Traditional Medicines, 1, pp.37~44 (2006)
- Biswas SJ, "Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB-induced hepatocarcinogenesis in mice", BMC Complement Altern Med, 2, pp.4~ (2002)
- Kundu S, "Cadmium induces lung inflammation independent of lung cell proliferation: a molecular approach", J Inflamm, 6, pp.19~ (2009)
- Kollinga A, "Comparison of primary lung tumour incidences in the rat evaluated by the standard microscopy method and by multiple step sections", Exp Toxicol Pathol, 60(4-5), pp.281~288 (2008)
- Chakraborty D, "Antihyperglycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade", Exp Biol Med, 237(1), pp.64~76 (2012)
- Chowdhury R, "In vitro and in vivo reduction of sodium- arsenite-induced toxicity by aqueous garlic extract", Food Chem Toxicol, 46(2), pp.740~751 (2008)
- Sholl LM, "EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry", Am J Clin Pathol, 133(6), pp.922~934 (2010)
- Yokoyama T, "EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small-cell lung cancer cells", Plos One, 6(11), pp.e25507~ (2011)
- Khuda-Bukhsh AR, "Can homeopathic arsenic remedy combat arsenic poisoning in humans exposed to groundwater arsenic contamination? a preliminary report on first human trial", Evid Based Complement Alternat Med, 2(4), pp.537~548 (2005)
- Ji BN, "Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumour growth in vivo", J Agric Food Chem, 57(16), pp.7596~7604 (2009)
- Khuda-Bukhsh AR, "Laboratory research in homeopathy: pro", Integr Cancer Ther, 5(4), pp.320~332 (2006)
- Khuda-Bukhsh AR, "Modulation of signal proteins: a plausible mechanism to explain how a potentized drug Secale Cor 30C diluted beyond Avogadro’s limit combats skin papilloma in mice", Evid Based Complement Alternat Med, pp.2011~ (2011)